Studies to advance novel drugs to treat obesity and associated cardiometabolic diseases

Project: Research project

Project Details

StatusActive
Effective start/end date11/1/25 → 10/31/26

Funding

  • Ridgeline Therapeutics, LLC ( Award # ): $15,764.16